ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
다우존스 지수
38,686.32
1.51%
Bitcoin
67,719.77
0.35%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Jazz Pharmaceuticals PLC (JAZZ)

  7. Jazz Pharmaceuticals PLC (JAZZ) 뉴스

JAZZ

Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:JAZZ
일자시간출처헤드라인심볼기업
2024/06/0121:05PR Newswire (US)Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
2024/06/0106:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/05/3020:30PR Newswire (US)Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
2024/05/3005:15PR Newswire (US)Jazz Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/05/3005:15PR Newswire (US)Jazz Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/05/2920:45PR Newswire (US)Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract CancerNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/05/2221:00PR Newswire (US)Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee VolunteerismNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/05/0806:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/05/0205:10PR Newswire (US)Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/05/0205:10PR Newswire (US)Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/05/0205:05PR Newswire (US)Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial GuidanceNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/04/2505:05PR Newswire (US)Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
2024/04/1805:15PR Newswire (US)Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
2024/04/1020:45PR Newswire (US)Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual MeetingNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/04/0220:30PR Newswire (US)Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract CancerNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/1305:15PR Newswire (US)Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/1305:15PR Newswire (US)Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0908:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0811:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0811:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0811:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0811:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0808:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0609:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0609:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0609:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0609:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0609:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0609:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
2024/03/0609:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
 검색 관련기사 보기:NASDAQ:JAZZ

최근 히스토리

NASDAQ
GOOGL
Alphabet
FX
USDJPY
US Dollar vs Yen
CCOM
US30
US 30
AMEX
SPY
SPDR S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
SPI
SP500
S&P 500
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
CCOM
SILVER
SILVER
NYSE
XOM
Exxon Mobil
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유